Keeping pace with immuno-oncology research breakthroughs and biomarker identification

2016년 5월 24일

In this webinar, Adrian Benjamin PhD, and Kimberly Robasky PhD detail how NGS technology can accelerate biomarker identification and bring down costs for research subject screening and safety monitoring – potentially making new treatments more effective. Among those technologies is RNA-Seq. Adrian and Kimberley summarize the clinical relevance of RNA-Seq, when and how to use expression profiling correctly, some common challenges and associated remedies. Webinar at a glance - Learn how legacy RNA-Seq datasets can be revisited for new insights to keep pace with today’s rapid advance of therapeutic breakthroughs - Learn how RNA-Seq provides high-throughput, comprehensive, direct measurement of functionally relevant molecular processes - Learn more about key applications for RNA-Seq in immuno-oncology Presenters: Adrian Benjamin, PhD Commercial Development Manager, Illumina Kimberley Robasky, PhD Associate Director, Lead Scientist, Bioinformatics and Clinical Systems Product Manager Q2 Solutions View related webinars RNA-Seq Techniques in Action http://mkt.illumina.com/CPBU-RNA-SeqWorkflows-Webinar-Landingpage-BoReese-Q32015.html?cstat=Attended%20On-demand View related videos Propelling Progress with RNA-Seq https://www.youtube.com/watch?v=qWd0N-Xj9y0 View related information Introduction to RNA Sequencing http://www.illumina.com/techniques/sequencing/rna-sequencing.html Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc

다음을 통해 기사 공유하기: